76 related articles for article (PubMed ID: 31549319)
1. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer.
Nakashima Y; Saeki H; Hu Q; Tsuda Y; Zaitsu Y; Hisamatsu Y; Ando K; Kimura Y; Oki E; Mori M
Ann Surg Oncol; 2020 Feb; 27(2):492-498. PubMed ID: 31549319
[TBL] [Abstract][Full Text] [Related]
2. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
Xiao X; Fang PH; Zhou JF; Li XK; Shang QX; Yang YS; Luan SY; Chen LQ; Yuan Y
Ann Surg Oncol; 2024 Jun; 31(6):3819-3829. PubMed ID: 38245646
[TBL] [Abstract][Full Text] [Related]
3. The Optimal Definition of Sarcopenia for Predicting Postoperative Pneumonia after Esophagectomy in Patients with Esophageal Cancer.
Nambara M; Miki Y; Tamura T; Yoshii M; Toyokawa T; Tanaka H; Lee S; Muguruma K; Shibata T; Ohira M
World J Surg; 2021 Oct; 45(10):3108-3118. PubMed ID: 34189621
[TBL] [Abstract][Full Text] [Related]
4. Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer.
Kanemura T; Takeoka T; Sugase T; Urakawa S; Masuike Y; Shinno N; Hara H; Kitakaze M; Kubo M; Mukai Y; Sueda T; Hasegawa S; Akita H; Nishimura J; Wada H; Yasui M; Omori T; Miyata H
Ann Surg Oncol; 2024 Feb; 31(2):818-826. PubMed ID: 37989955
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia impacts perioperative and survival outcomes after esophagectomy for cancer: a multicenter study.
Park JS; Colby M; Seyfi D; Leibman S; Laurence JM; Smith G; Falk GL; Sandroussi C
J Gastrointest Surg; 2024 Jun; 28(6):805-812. PubMed ID: 38548573
[TBL] [Abstract][Full Text] [Related]
6. Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study.
Klevebro F; Elliott JA; Slaman A; Vermeulen BD; Kamiya S; Rosman C; Gisbertz SS; Boshier PR; Reynolds JV; Rouvelas I; Hanna GB; van Berge Henegouwen MI; Markar SR
Ann Surg Oncol; 2019 Sep; 26(9):2864-2873. PubMed ID: 31183640
[TBL] [Abstract][Full Text] [Related]
7. The treatment efficacy and prognosis of each treatment in early postoperative recurrence of esophageal squamous cell carcinoma.
Ohsawa M; Hamai Y; Emi M; Ibuki Y; Kurokawa T; Yoshikawa T; Hirohata R; Kitasaki N; Okada M
Surg Today; 2024 Jan; 54(1):53-63. PubMed ID: 37225930
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative psoas muscle index, a surrogate for sarcopenia; as a predictor of post-esophagectomy complications.
Yunrong T; Jin WW; Mahendran HA; Koon YB; Jahit S; Kamaruddin MA; Anuar N; Daud NAM
Dis Esophagus; 2024 Apr; 37(4):. PubMed ID: 38163959
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcomes and survival following esophagectomy for squamous cell carcinoma with or without liver cirrhosis: retrospective cohort study.
Park SY; Shin J; Jeon YJ; Lee J; Cho JH; Kim HK; Choi YS; Zo JI; Shim YM
Int J Surg; 2024 May; 110(5):2894-2901. PubMed ID: 38349217
[TBL] [Abstract][Full Text] [Related]
10. Protocol of a pilot randomized clinical trial to evaluate nutritional support and rehabilitation on prevention of skeletal muscle mass loss during neoadjuvant chemotherapy in patients with esophageal cancer.
Miki Y; Nishi S; Tamura T; Imai T; Nambara M; Fukuoka T; Yoshii M; Toyokawa T; Lee S; Fujii H; Yoshida H; Ikebuchi M; Maeda K
PLoS One; 2024; 19(4):e0302003. PubMed ID: 38635741
[TBL] [Abstract][Full Text] [Related]
11. Changes in Sarcopenia Status Predict Survival Among Patients with Resectable Esophageal Cancer.
Jogiat UM; Baracos V; Turner SR; Eurich D; Filafilo H; Rouhi A; Bédard A; Bédard ELR
Ann Surg Oncol; 2023 Nov; 30(12):7412-7421. PubMed ID: 37466867
[TBL] [Abstract][Full Text] [Related]
12. Significance of skeletal muscle index-to-body mass index ratio as a predictor of post-surgical bleeding after mastectomy in patients with breast cancer.
Morikawa H; Oba T; Kiyosawa N; Iji R; Amitani M; Chino T; Shimizu T; Ono M; Ito T; Kanai T; Maeno K; Ito KI
Breast Cancer; 2023 Nov; 30(6):933-942. PubMed ID: 37440158
[TBL] [Abstract][Full Text] [Related]
13. Correlation between sarcopenia and esophageal cancer: a narrative review.
Li S; Xie K; Xiao X; Xu P; Tang M; Li D
World J Surg Oncol; 2024 Jan; 22(1):27. PubMed ID: 38267975
[TBL] [Abstract][Full Text] [Related]
14. The association between skeletal muscle mass index (SMI) and survival after gastrectomy: A systematic review and meta-analysis of cohort studies.
Salavatizadeh M; Soltanieh S; Radkhah N; Ataei Kachouei AH; Bahrami A; Khalesi S; Hejazi E
Eur J Surg Oncol; 2023 Nov; 49(11):106980. PubMed ID: 37451925
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of a New Muscle Parameter in Patients with Resectable Gastric Cancer: A Pooled Analysis of Three Prospective Trials.
Zhong Q; Huang JB; Lu J; Xue LW; Lin GT; Xie JW; Lin JX; Zheng CH; Huang CM; Li P
Ann Surg Oncol; 2024 May; 31(5):3005-3016. PubMed ID: 38270825
[TBL] [Abstract][Full Text] [Related]
16. Preoperative inspiratory muscle weakness as a risk factor of postoperative pulmonary complications in patients with esophageal cancer.
Okura K; Suto A; Sato Y; Takahashi Y; Hatakeyama K; Nagaki Y; Wakita A; Kasukawa Y; Miyakoshi N; Minamiya Y
J Surg Oncol; 2023 Dec; 128(8):1259-1267. PubMed ID: 37671598
[TBL] [Abstract][Full Text] [Related]
17. Effective Postoperative Surveillance Protocol after Thoracoscopic Esophagectomy Focusing on Symptoms in Patients with Esophageal Cancer.
Tajima K; Koyanagi K; Ozawa S; Kazuno A; Yamamoto M; Shoji Y; Yatabe K; Kanamori K; Zhao H; Mori M
J Am Coll Surg; 2023 Nov; 237(5):771-778. PubMed ID: 37427845
[TBL] [Abstract][Full Text] [Related]
18. Skeletal Muscle Mass Index Reduction Rate as a Prognostic Indicator for Patients Undergoing Pancreatectomy for Pancreatic Cancer.
Mita J; Maeda T; Tsujita E; Hashimoto N; Fujikawa R; Ono Y; Sakai A; Tanaka S; Matono R; Ohmine T; Kometani T; Yamaguchi S; Konishi K; Hashimoto K
Cancer Diagn Progn; 2024; 4(3):301-308. PubMed ID: 38707741
[TBL] [Abstract][Full Text] [Related]
19. The Evaluation of Sarcopenia before Neoadjuvant Chemotherapy Is Important for Predicting Postoperative Pneumonia in Patients with Esophageal Cancer.
Nishi S; Miki Y; Imai T; Nambara M; Miyamoto H; Tamura T; Yoshii M; Toyokawa T; Tanaka H; Lee S; Maeda K
Dig Surg; 2023; 40(5):153-160. PubMed ID: 37497924
[TBL] [Abstract][Full Text] [Related]
20. ASO Author Reflections: Significance of Skeletal Muscle Loss After Neoadjuvant Chemoradiation for Esophageal Cancer.
Xiao X; Fang PH; Zhou JF; Yuan Y
Ann Surg Oncol; 2024 Jun; 31(6):3854-3855. PubMed ID: 38265614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
